Skip to main content
Premium Trial:

Request an Annual Quote

Motif Collaborating with Imperial College London on Diabetes, Obesity Genetics Research

NEW YORK (GenomeWeb News) – The specialized genetics company Motif BioSciences Inc. is forming a new partnership with the Imperial College London aimed at deciphering the genetics of diabetes, obesity, and other related metabolic and cardiovascular disorders, the company announced today.

Motif, which is an Amphion Innovations partner company, plans to team up with Imperial College’s head of genomic medicine Philippe Froguel, who has extensive experience studying metabolic diseases. Once they receive appropriate permission, Motif plans to access genetic samples and clinical data that Froguel and his collaborators have collected in Morocco.

Using their genomic analysis tools and high density microarray technology, Motif hopes to identify genomic variants that predispose some individuals to diabetes, obesity, and other diseases. This, in turn, may reveal new druggable targets and molecular biomarkers, they said.

“This is Motif’s first major project in this field and we are excited to be working with such a highly respected, ground-breaking team,” Motif CEO Zaki Hosny said in a statement.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.